Double trouble: can stronger nicotine meds help you quit both cigarettes and E-Cigs?
NCT ID NCT06087328
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether higher doses of nicotine patches and lozenges help people quit both smoking and vaping. 46 adults who used both cigarettes and e-cigarettes daily took part. Researchers measured how many days they stayed away from both products and checked for side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 2
Tests whether the treatment actually works, and watches for side effects, in a larger group.
- Participants
-
46 people
The number who actually took part.
- Started
-
Dec 2023
- Finished
-
Nov 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age 18yrs + * Daily nicotine-containing e-cigarette user (25+ days per previous month) * E-cigarette use 5+ times/day * E-cigarette use \> 1year * Smoking \>1 cigarette on 5-7 days per week * Interest in quitting smoking and e-cigarette within the next month (\>7 on 10-point scale) * Willingness to use NRT * Able to receive text messages/email * Mailing address in South Carolina. Exclusion Criteria: * Medical conditions contraindicated to NRT use (including pregnancy, past month myocardial infarction, current cardiac arrhythmia, current angina, uncontrolled vascular disease, or medical conditions in which consumption of phenylalanine is contraindicated) * Individuals reporting current use of other nicotine-containing products and/or smoking cessation medications * Those who vape non-nicotine substances * Individuals unable to consent (e.g. significant cognitive deficit, non-English speaking).
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cigarette smoking are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Medical University of South Carolina - Charleston
Charleston, South Carolina, 29403, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Texts and wearables team up to help latinos quit smoking and get moving
- Can an AI chatbot help cancer patients kick the habit?
- Does the clock matter? scientists randomize when Quit-Smoking chatbots ping you
- Can a WhatsApp message help smokers quit?
- Practice quitting: a new way to help smokers who Aren't ready to stop?
- Can a combined program help veterans in substance use care quit smoking?